Home / 人员 / 朱 王强
Nicolas Zhu

朱 王强

合伙人

CMS,中国
上海代表处
中国上海市南京西路1266号 恒隆广场二期3108室
上海 200040
中国
语言技能 中文, 法文, 英文

朱王强为生命科学和医疗保健行业的客户提供全方面的法律咨询与服务,包括公司法、知识产权法及其他领域。他在公司法与商法、并购、专利权、商标保护、产品责任、分销合同和争议解决等发面为客户提供全面的法律意见与服务。他的客服主要为医院、制药、医疗器械、化妆品及消费品公司等。

朱王强加入CMS,中国已超过17年,在此之前他曾于上海的一家顶尖法国律师事务所和内资所分别任职。

朱王强的工作语言为汉语(普通话),法语和英语。

更多 更少

相关经验

  • A French pharmaceutical company on the establishment of a representative office, strategy of the establishment of a veterinary trading company and clinics in China. 
  • A manufacturer & distributor of dental anaesthesia products on the acquisition of a domestic pharmaceutical trading company in China, on medical device counterfeiting actions and trademark portfolio, and domain name management and disputes in China. 
  • The world's largest maker of dreaded flu shot on biopharmaceutical product liability cases with various local courts, hospitals and centres for disease control and prevention. 
  • A multinational pharmaceutical and cosmetics company on the establishment of a management company in China. 
  • A research-based global pharmaceutical company on regulatory due diligence of the acquisition of a pharmaceutical company in China.
  • A famous French bio-pharmaceutical company on product liability litigations and disputes in cooperation with/against Chinese hospitals and local Centers of Disease Control.
  • A global medical devices company on the restructuring of Chinese subsidiaries. 
  • The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on the implementation of patent rights in China.
  • A leading European biomedical company on patent licensing and technology transfer relating to the acquisition and restructuring of a China based biochemistry and medicine manufacturer. 
  • One of Europe’s largest chemical and pharmaceutical companies on the sale of a chemical business section including several PRC subsidiaries to another multinational company in China. 
更多 更少

教育背景

  • 2005年 – 通过中国司法考试
  • 2001年 – 上海华东政法大学法学学士
更多 更少

出版物

  • Acquisition d'une société en Chine-nouveautés à prendre en compte | Fusions and Acquisitions Magazine.
  • Manufacturing Practices Upgrade Could Offer Opening for Global Companies | Interviewed by Bloomberg BNA.
  • Drug Commodity Name Protection – A Pitfall in China's New Revised Trademark Law | Bloomberg BNA.
  • China's drug price reforms: Much of the same? | China Law and Practice.
  • La Chine et la France ont signe une nouvelle convention fiscale-Quels changements en attendre (China and France Signed New Double Taxation Treaty) | Option Finance.
  • A warning for foreign hospitals | China Law & Practice.
  • Doctor on Call: Reformers Dail-up Dose of Telemedicne | Interviewed by GBI.
  • Not so free zone | Interviewed by China Law & Practice.
更多 更少

    2002年加入CMS上海代表处,任高级律师。之前曾分别在法国一家律师事务所驻上海办事处以及一家知名内资律师事务所任职。     主要负责就公司法、知识产权法、税法、产品责任法等事务向客户提供意见。擅长处理铁路、汽车与制药行业的兼并与收购、知识产权诉讼与执行、争议解决等事务。     1997年~2001年,就读于华东政法大学,获法学(经济法)学士学位,2005年取得中国律师资格。     朱律师负责处理公司法务、知识产权事务。

更多 更少
05/04/2016
Ne­w G­CP o­f Me­di­ca­l Devi­ce­s
On 23 Ma­r­ch 2016, the Chi­na Foo­d an­d D­ru­g­s A­dmi­ni­st­ra­tion (“CFDA”) an­d Na­tio­na­l Hea­lth an­d Fa­mi­ly Plan­ning Co­mmi­ssion (“N­HFPC”) join­tly i­ssue­d the ne­w Goo­d Cli­ni­ca­l P­ra­cti­ce o­f Me­di­ca­l Devi­ce­s (“Ne­w G­CP”). Thi­s Ne­w G­CP wi­ll re­pla­ce the P­rovi­sion­s on
05/04/2016
Chi­na En­cou­ra­ge­s In­nova­tive D­ru­g by Mo­di­fying I­ts D­ru­g Cla­ssi­fi­ca­tion Ru­le­s
Fo­llo­wing the ne­w ru­le­s o­f cla­ssi­fi­ca­tion o­f me­di­ca­l devi­ce­s e­ffe­ctive a­s o­f 1st Ja­nua­r­y 2016, the Chi­na Foo­d an­d D­ru­g A­dmi­ni­st­ra­tion (“CFDA”) i­ssue­d a ci­r­cu­la­r re­ga­r­ding the re­fo­r­m o­f che­mi­ca­l d­ru­g re­gi­st­ra­tion cla­ssi­fi­ca­tion on 4 Ma­r­ch 2016 (“Ci­r­cu

信息推送

仅显示
09 六月 2020
兽药生产质量管理规范新标准展望
08 七月 2020
CMS E­xper­t Gui­de to cli­ma­te chan­ge ta­x re­fo­r­ms an­d in­cen­tive­s
05 六月 2020
修订后的药品注册管理办法要点
19 四月 2017
CMS E­xper­t Gui­de to t­ran­sfer p­ri­cing do­cu­men­ta­tion re­qui­re­men­ts
Thi­s CMS E­xper­t Gui­de i­s an e­xce­llen­t su­ppo­r­t fo­r in­ter­na­tio­na­l g­rou­ps to ma­na­ge an­d se­cu­re thei­r t­ran­sfer p­ri­cing po­li­cy in an envi­ron­men­t whe­re the p­rovi­sion­s o­f na­tio­na­l la­ws a­re fa­r f­ro­m being ha­r­mo­ni­se­d.
03 六月 2020
药品生产监督管理办法要点
10 四月 2017
CMS E­xper­t Gui­de to t­ran­sfer p­ri­cing ru­le­s an­d TP la­w
A­re you loo­king fo­r in­fo­r­ma­tion on t­ran­sfer p­ri­cing ru­le­s an­d TP la­w? Thi­s CMS E­xper­t Gui­de p­rovi­de­s you wi­th ever­ything you nee­d to k­no­w.
09 四月 2020
与COVI­D-19疫情有关的医疗器械出口的新要求
25 十一月 2019
长江三角洲区域医疗器械注册人制度试点展望
15 十月 2019
新《疫苗管理法》规定的接种后异常反应赔偿要点
09 十月 2019
新《药品管理法》
09 九月 2019
中国疫苗管理法
16 八月 2019
关于定制医疗器械的近期法规要点